Aplenzin - 0024-5812-30 - (bupropion hydrobromide)

Alphabetical Index


Drug Information of Aplenzin

Product NDC: 0024-5812
Proprietary Name: Aplenzin
Non Proprietary Name: bupropion hydrobromide
Active Ingredient(s): 522    mg/1 & nbsp;   bupropion hydrobromide
Administration Route(s): ORAL
Dosage Form(s): TABLET, EXTENDED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of Aplenzin

Product NDC: 0024-5812
Labeler Name: sanofi-aventis U.S. LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA022108
Marketing Category: NDA
Start Marketing Date: 20090330

Package Information of Aplenzin

Package NDC: 0024-5812-30
Package Description: 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0024-5812-30)

NDC Information of Aplenzin

NDC Code 0024-5812-30
Proprietary Name Aplenzin
Package Description 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0024-5812-30)
Product NDC 0024-5812
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name bupropion hydrobromide
Dosage Form Name TABLET, EXTENDED RELEASE
Route Name ORAL
Start Marketing Date 20090330
Marketing Category Name NDA
Labeler Name sanofi-aventis U.S. LLC
Substance Name BUPROPION HYDROBROMIDE
Strength Number 522
Strength Unit mg/1
Pharmaceutical Classes Aminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA]

Complete Information of Aplenzin


General Information